Company / Profit Margin
Celldex Therapeutics, Inc. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-16748.0%
FY2025
5-year range
-16748.0% / -2054.8%
FY2023-FY2025
Trend
-644.8%
vs FY2024
Sector context
#154 of 155
Health Care
What the data says
Profit Margin changed -645% YoY in FY2025, a notable deviation from the 2-year average annual change of -327%.
Based on SEC 10-K filings.
-16748.0% in FY2025.
Declined from -2054.8% to -16748.0% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 155This company -16748.0% Sector average -254.2%
▼
-6488.8% below sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 644.8% year-over-year.
- Currently 16493.8pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -16748.0% | -644.8% |
| FY2024 | -2248.8% | -9.4% |
| FY2023 | -2054.8% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026